Reference
Zeng L, et al. EGFR exon 18 DelE709_T710insD as an Acquired Resistance Mechanism to Afatinib in an Advanced EGFR exon 18 E709H Lung Adenocarcinoma. Journal of Thoracic Oncology 13: e93-e95, No. 6, Jun 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.01.006 - China
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1708, 27 (2018). https://doi.org/10.1007/s40278-018-48120-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-48120-1